Skip to main content
x
About searching

Search results

  1. ESMO 2023 – sabestomig has it all to do in TIM-3

    ESMO 2023 – sabestomig has it all to do in TIM-3 …

    - 10/21/2023 - 18:04

  2. ESMO 2023 – Amgen’s Steap1 project spurs cautious optimism

    ESMO 2023 – Amgen’s Steap1 project spurs cautious …

    - 10/21/2023 - 15:55

  3. ESMO 2023 – Amgen keeps tarlatamab filing plans under wraps

    ESMO 2023 – Amgen keeps tarlatamab filing plans under … DLL3 positivity 40% ORR with 10mg dose (40/100 pts) at ESMO 2023, responses seen regardless of DLL3 expression; …

    - 10/21/2023 - 10:50

  4. ESMO 2023 – Perla gives Jemperli combos more backing

    ESMO 2023 – Perla gives Jemperli combos more backing …

    - 10/21/2023 - 11:10

  5. After failing to get Seagen Merck turns to Daiichi

    … TROP2 4 Tropion-Lung01 & Tropion-Breast01 data at ESMO 2023 Astra paid $1bn up front, $1bn due in …

    - 10/21/2023 - 15:55

  6. ESMO 2023 – Jiangsu Hengrui sets a low bar in KRAS G12D inhibition

    ESMO 2023 – Jiangsu Hengrui sets a low bar in KRAS G12D …

    - 10/18/2023 - 16:33

  7. ESMO 2023 – duelling PD-1 drugs

    ESMO 2023 – duelling PD-1 drugs Quick …

    - 10/18/2023 - 15:52

  8. ESMO 2023 – tarlatamab hits the target for Amgen

    ESMO 2023 – tarlatamab hits the target for Amgen … T-cell engager Ph2 Dellphi-301 3L SCLC (data at ESMO 2023) BI 764532 Boehringer Ingelheim … Ph1 SCLC & neuroendocrine tumours (focus on NETs at ESMO 2023) HPN328 Harpoon Therapeutics …

    - 10/18/2023 - 15:54

  9. ESMO 2023 – some Tropion fears allayed

    ESMO 2023 – some Tropion fears allayed …

    - 10/20/2023 - 11:52

  10. ESMO 2023 – butterflies for J&J

    ESMO 2023 – butterflies for J&J Full …

    - 10/20/2023 - 19:13